Age-specific differences between conventional and ambulatory daytime blood pressure values by Conen, David et al.
1073
Elevated blood pressure (BP) is one of the strongest risk fac-tors for morbidity and mortality worldwide.1 BP-lowering 
treatment has been shown to be highly effective in preventing 
hypertension-related cardiovascular events.2 Accordingly, an 
accurate diagnosis of hypertension is crucial to target treatment 
to those individuals at high risk for adverse events.
Abstract—Mean daytime ambulatory blood pressure (BP) values are considered to be lower than conventional BP values, but data on 
this relation among younger individuals <50 years are scarce. Conventional and 24-hour ambulatory BP were measured in 9550 
individuals not taking antihypertensive treatment from 13 population-based cohorts. We compared individual differences between 
daytime ambulatory and conventional BP according to 10-year age categories. Age-specific prevalences of white coat and masked 
hypertension were calculated. Among individuals aged 18 to 30, 30 to 40, and 40 to 50 years, mean daytime BP was significantly 
higher than the corresponding conventional BP (6.0, 5.2, and 4.7 mm Hg for systolic; 2.5, 2.7, and 1.7 mm Hg for diastolic BP; 
all P<0.0001). In individuals aged 60 to 70 and ≥70 years, conventional BP was significantly higher than daytime ambulatory BP 
(5.0 and 13.0 mm Hg for systolic; 2.0 and 4.2 mm Hg for diastolic BP; all P<0.0001).The prevalence of white coat hypertension 
exponentially increased from 2.2% to 19.5% from those aged 18 to 30 years to those aged ≥70 years, with little variation between 
men and women (8.0% versus 6.1%; P=0.0003). Masked hypertension was more prevalent among men (21.1% versus 11.4%; 
P<0.0001). The age-specific prevalences of masked hypertension were 18.2%, 27.3%, 27.8%, 20.1%, 13.6%, and 10.2% among 
men and 9.0%, 9.9%, 12.2%, 11.9%, 14.7%, and 12.1% among women. In conclusion, this large collaborative analysis showed that 
the relation between daytime ambulatory and conventional BP strongly varies by age. These findings may have implications for 
diagnosing hypertension and its subtypes in clinical practice.  (Hypertension. 2014;64:1073-1079.) • Online Data Supplement
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Conventional BP monitoring (CBPM) in the doctor’s office 
has been the standard of care for many decades, despite the 
fact that this technique has many potential limitations. Some 
of these limitations are minimized through the use of 24-hour 
ambulatory BP monitoring (ABPM). Accordingly, ABPM has 
been shown to be a better predictor of cardiovascular compli-
cations and death than CBPM3,4 and may help to implement a 
more efficient BP-lowering treatment regimen.5,6
ABPM values are usually considered to be lower than 
conventional BP (CBP) values in the same individual. 
Accordingly, diagnostic thresholds for hypertension based on 
24-hour ABPM are lower than those for CBPM.7 However, 
most studies to determine the association between ABPM and 
CBPM have been performed in middle-aged to elderly indi-
viduals, and it is relatively unknown whether this relation is 
similar among younger individuals. Usually, younger individ-
uals are more physically active than older individuals, which 
may directly affect daytime ambulatory BP (ABP) values. 
Evidence-based thresholds are important in younger adults, 
given the long-term implications of diagnosing hypertension 
in this population group. To address this issue, we performed a 
large collaborative analysis among 9550 participants not tak-
ing BP-lowering drugs and representing a wide age range.
Methods
The International Database on Ambulatory blood pressure in relation 
to Cardiovascular Outcomes (IDACO) was assembled from random 
population-based studies with available information on CBPM and 
ABPM, baseline cardiovascular risk factors, and fatal and nonfatal 
outcomes during follow-up. Details about study selection and aims 
of the consortium have been described previously.8 Currently, the 
IDACO database contains 12 randomly recruited population cohorts 
and 12 725 participants. For the purpose of this analysis, we excluded 
303 participants aged <18 years, 1389 with missing CBPM, 1878 
with incomplete ABPM (<10 valid daytime measurements or <5 
valid nighttime measurements),8 and 1649 participants currently tak-
ing antihypertensive treatment, such that 7506 IDACO participants 
were included in this study.
To increase the number of individuals aged <40 years, data from 
the population-based Genetic and Phenotypic Determinants of Blood 
Pressure and Other Cardiovascular Risk Factors (GAPP) study were 
added to the IDACO data set. GAPP is an ongoing prospective cohort 
study among all inhabitants of the Principality of Liechtenstein aged 
25 to 41 years. The study methodology has been described in detail 
previously.9 In brief, between 2010 and 2013, 2170 participants have 
been enrolled into GAPP. Main exclusion criteria are prevalent car-
diovascular disease, a body mass index ≥35 kg/m2, and current intake 
of antidiabetic drugs. For the purpose of this study, 2 participants with 
missing CBPM, 90 participants with incomplete ABPM (<10 valid 
daytime measurements or <5 valid nighttime measurements; details 
shown in Table S1 in the online-only Data Supplement), and 34 par-
ticipants on antihypertensive drug treatment were excluded, leaving 
2044 individuals in the GAPP database.
The combined data set for this analysis contained 9550 partici-
pants. Written informed consent was obtained from every participant. 
All responsible local ethics committees approved the corresponding 
study protocols.
Blood Pressure Monitoring
Details on CBPM and ABPM are provided in the Expanded Methods 
available in the online-only Data Supplement. In brief, trained observ-
ers measured CBPM with validated devices, using the appropriate 
cuff size, with participants in the sitting position. Observer-measured 
CBP was the average of 2 consecutive readings obtained either at the 
persons’ home or at an examination center.
ABPM was obtained by validated automated devices programmed 
to perform measurements every 15 to 30 minutes during daytime and 
every 30 to 60 minutes during nighttime. Details on time intervals 
between readings and numbers of programmed and recorded read-
ings in each cohort are provided in Table S1. Daytime and nighttime 
BP were defined according to short fixed clock–time periods with 
daytime and nighttime ranging from 10.00 AM to 8.00 PM and from 
midnight to 6.00 AM in Europeans and South Americans and from 
8.00 AM to 6.00 PM and from 10.00 PM to 4.00 AM in Asians.10 
Sensitivity analyses using a diary-based definition of awake and 
Table 1. Baseline Characteristics Stratified by Age Categories
n=9550
Age Categories, y
P Value18–30 30–40 40–50 50–60 60–70 ≥70
No. of participants 1543 2063 2141 1676 1408 719 …
Age, y 26±3.0 35±2.9 43±2.8 54±3.0 63±2.6 74±4.2 …
Sex (male %) 699 (45.3) 955 (46.3) 1040 (48.6) 787 (47.0) 727 (51.6) 422 (58.7) <0.0001
BMI, kg/m2 23.3±3.6 24.5±4.0 25.3±4.0 25.8±4.2 25.7±4.2 25.1±4.1 <0.0001
Smoking status (%) 0.002
  Former/never 1107 (71.8) 1511 (73.3) 1476 (69.1) 1166 (69.6) 997 (70.9) 542 (75.7) …
  Current 434 (28.2) 550 (26.7) 660 (30.9) 509 (30.4) 410 (29.1) 174 (24.3) …
Any alcohol intake (%) 720 (46.7) 937 (45.5) 1137 (53.4) 834 (50.6) 753 (54.4) 339 (48.5) <0.0001
Ethnicity (%) <0.0001
  White 1508 (97.7) 1946 (94.3) 1934 (90.3) 1263 (75.4) 959 (68.1) 491 (68.3) …
  Asians 34 (2.2) 116 (5.6) 207 (9.7) 347 (20.7) 326 (23.2) 120 (16.7) …
  Others 1(0.1) 1 (0.1) 0 (0.0) 66 (3.9) 123 (8.7) 108 (15.0) …
History of CVD (%) 25 (1.6) 38 (1.8) 35 (1.6) 125 (7.5) 195 (13.9) 144 (20.0) <0.0001
History of DM (%) 11 (0.7) 20 (1.0) 46 (2.2) 100 (6.0) 138 (9.8) 79 (11.0) <0.0001
Office hypertension (%)* 112 (7.3) 237 (11.5) 372 (17.4) 498 (29.7) 615 (43.7) 420 (58.4) <0.0001
Data are mean±SD or number and percentages. BMI indicates body mass index; CVD, cardiovascular disease; and DM, diabetes 
mellitus.
*Office hypertension was defined as conventional systolic blood pressure ≥140 mm Hg or conventional diastolic blood pressure 
≥90 mm Hg.
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asleep BP were performed among 7185 participants with this avail-
able information.
Normotension was defined as systolic BP <140 mm Hg and dia-
stolic BP <90 mm Hg on CBPM and as daytime systolic BP <135 
mm Hg and daytime diastolic BP <85 mm Hg on ABPM. True nor-
motension was defined as normal CBP and normal ABP, white coat 
hypertension as elevated CBP and normal ABP, masked hypertension 
as normal CBP and elevated ABP, and sustained hypertension as el-
evated CBP and elevated ABP.7
Other Covariables
Cohort-specific questionnaires were used to obtain information on 
each participant’s medical history, smoking, and alcohol consump-
tion. With regard to alcohol, participants were dichotomized as non-
drinkers versus current drinkers of any amount of alcohol. Body mass 
index was calculated as body weight in kilograms divided by height 
in meters squared.
Statistical Methods
Baseline characteristics across age deciles were compared using 
analysis of variance or Kruskal–Wallis tests for continuous variables, 
as appropriate, and χ2 tests for categorical variables. Within each age 
category, we calculated mean CBP and daytime ABP and compared 
the individual BP indices using paired t tests. We assessed whether 
our findings differed in the subgroup of individuals with hypertension 
on CBP, who are usually considered for ABPM according to current 
guidelines.7 To exclude an important influence of the device technol-
ogy used, we repeated our main analyses in 3 cohorts, where oscil-
lometric devices for both CBPM and ABPM were available. We also 
assessed whether our results were similar in those 6 cohorts where 
CBPM was obtained in the clinic.
We then assessed whether the age-specific differences between 
mean daytime ABP and CBP were independent of other baseline 
characteristics using multivariable linear regression analysis. Sex, 
age, body mass index, smoking, alcohol consumption, history of dia-
betes mellitus, history of cardiovascular disease, and ethnicity were 
prespecified covariables for these models. Because BP measurements 
within an individual study center may be correlated, study center was 
included as a random effect variable in these models. Separate mod-
els were constructed for systolic and diastolic BP. We used analyses 
stratified by sex to assess for sex-specific differences of our results, 
and we formally tested for such differences by using multiplicative 
interaction tests.
Finally, we calculated the prevalence of true normotension, white 
coat hypertension, masked hypertension, and sustained hypertension 
as defined by current guidelines separately within each age category.7 
A daytime BP–based definition was used in the main analysis, and 
a sensitivity analysis was performed using a 24-hour BP of 130/80 
mm Hg as a threshold for ambulatory hypertension. We performed 
another sensitivity analysis where we used awake instead of daytime 
ABP for the definition of BP categories. Prevalences across catego-
ries were compared using χ2 tests. All analyses were performed using 
SAS version 9.3 (SAS Institute Inc, Cary, NC). A 2-tailed P value 
<0.05 was considered to indicate statistical significance.
Results
Baseline characteristics of the 9550 participants stratified by 
age deciles are shown in Table 1. Across categories of increas-
ing age, there was an increasing number of male participants, 
an increasing prevalence of diabetes mellitus and cardio-
vascular disease, and a lower prevalence of white individu-
als. Alcohol consumption, currently smoking cigarettes, and 
mean body mass index showed a nonlinear distribution across 
age categories. By design, none of the participants was taking 
BP-lowering therapy.
Mean systolic and diastolic CBP increased from 117 to 
149 mm Hg and from 74 to 82 mm Hg, respectively, from 
the youngest to the oldest age category, as shown in Table 2. 
Daytime systolic ABP values also increased with age, although 
the absolute increase was smaller when compared with CBP. 
There was a U-shaped relationship between age categories and 
daytime diastolic ABP (Table 2). Among individuals aged 50 
to 60 years, daytime ABP and CBP were similar (P=0.20 for 
Table 2. Differences Between Conventional and Ambulatory 
Daytime Blood Pressures According to Age Categories
Age, y n
Conventional 
SBP, mm Hg
Daytime  
SBP, mm Hg
Conventional 
DBP, mm Hg
Daytime  
DBP, mm Hg
18–30 1543 117.0±12.6 123.0±10.9 73.6±9.1 76.1±7.6
30–40 2063 118.6±12.9 123.8±11.3 76.8±9.3 79.5±8.1
40–50 2141 121.5±15.4 126.2±12.7 78.5±10.4 80.2±9.2
50–60 1676 128.6±19.1 129.1±14.1 80.1±11.7 79.8±9.6
60–70 1408 137.3±22.5 132.3±14.7 81.0. ± 11.9 79.0±9.1
≥70 719 148.8±27.9 135.7±15.3 81.6±12.7 77.4±9.7
Data are means±SD. DBP indicates diastolic blood pressure; and SBP, 
systolic blood pressure.
Figure 1. Differences between conventional and 
ambulatory daytime blood pressure according to age 
categories. Data are mean blood pressure differences 
(Daytime − conventional blood pressure). Error bars 
indicate standard errors of the mean differences. SBP 
indicates systolic blood pressure; and DBP, diastolic 
blood pressure.
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the difference in systolic BP and P=0.11 for the difference in 
diastolic BP). Mean systolic and diastolic daytime ABP were 
significantly higher than the corresponding CBP among indi-
viduals <50 years (all P<0.0001). Among individuals aged ≥60 
years, this relationship inversed, such that mean CBP values 
were significantly higher than daytime ABP values in this group 
(all P<0.0001). This age-dependent difference between day-
time ABP and CBP is summarized in Figure 1. Similar results 
were obtained when individually defined awake BP was used 
instead of daytime ABP based on short fixed clock–time peri-
ods (Figure 2; Table S2). Among 2254 individuals with hyper-
tension on CBP, daytime ABP was significantly lower in all age 
groups assessed (P<0.0001), except for systolic BP in those 
aged 18 to 30 years, as shown in Figure S1. Similar to the main 
results, the difference between CBP and daytime ABP strongly 
increased with age. In addition, similar BP relationships across 
age categories were obtained in the 3 cohorts that used only 
oscillometric devices (n=3625; Table S3) and in the 6 cohorts 
where CBP was measured in the clinic (n=7229; Table S4).
In multivariable linear regression analyses, age remained 
a significant predictor for the difference between daytime 
ABP and CBP. The β estimates (95% confidence interval) per 
1-year increase in age were 0.31 (0.29, 0.33; P<0.0001) for 
systolic BP and 0.09 (0.08, 0.11; P<0.0001) for diastolic BP.
Although men had higher BP values than women across 
all BP types and age groups, the age-dependent relationship 
between daytime ABP and CBP was similar for both men 
and women, as shown in Table 3 and Figures S2 and S3. 
Accordingly, multiplicative age by sex interaction tests in the 
multivariable regression models were not statistically signifi-
cant for either systolic (P=0.16) or diastolic (P=0.06) BP.
The prevalence of true normotension across increasing 
age categories was 79.6%, 70.5%, 62.9%, 54.5%, 42.2%, 
and 30.6% (P<0.0001). The prevalence of sustained hyper-
tension, white coat hypertension, and masked hypertension 
stratified by age categories is shown in Figure S4. Sustained 
Table 3. Conventional and Ambulatory Daytime Blood 
Pressures According to Age and Sex Categories
Age, y Sex n
Conventional 
SBP, mm Hg
Daytime  
SBP, mm Hg
Conventional 
DBP, mm Hg
Daytime  
DBP, mm Hg
18–30 Women 844 111.6±10.8 118.6±9.3 71.9±8.3 75.2±7.3
Men 699 123.5±11.5 128.3±10.4 75.7±9.5 77.2±7.8
30–40 Women 1108 113.4±11.3 118.8±9.3 74.1±8.6 77.1±7.4
Men 955 124.7±12.0 129.5±10.7 80.1±9.1 82.3±8.1
40–50 Women 1101 117.0±14.5 121.5±11.3 75.6±9.8 77.0±8.3
Men 1040 126.3±14.9 131.0±12.2 81.6±10.2 83.5±9.0
50–60 Women 889 126.6±19.5 126.6±13.7 78.1±11.8 77.5±9.4
Men 787 130.9±18.5 132.0±13.9 82.4±11.2 82.3±9.2
60–70 Women 681 134.6±21.9 130.9±14.6 79.6±12.1 77.6±8.8
Men 727 139.8±22.9 133.6±14.7 82.3±11.6 80.4±9.2
≥70 Women 297 145.9±26.2 134.4±15.1 81.0±13.2 76.1±10.0
Men 422 150.8±29.0 136.7±15.3 82.1±12.4 78.3±9.4
Data are means±SD. DBP indicates diastolic blood pressure; and SBP, 
systolic blood pressure.
Figure 2. Conventional and 
ambulatory daytime blood pressure 
according to age categories. Data 
are shown by age categories (in 
years) and represent blood pressure 
in mm Hg. A diary-based definition 
of awake blood pressure was 
used, an information available in 
7185 participants. CBP indicates 
conventional blood pressure; and 
ABP, ambulatory blood pressure.
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hypertension exponentially increased across increasing age 
groups from 5.1% in the youngest age group to 38.9% in those 
aged ≥70 years (P<0.0001). A similar relationship with age 
was found for white coat hypertension, which was observed in 
2.2% of participants aged 18 to 30 years and 19.5% of those 
aged ≥70 years (P<0.0001). In contrast, the prevalence of 
masked hypertension showed an inverse U-shaped relation-
ship with age. Although masked hypertension was less com-
mon in the youngest and oldest age groups (13.2% and 11.0%, 
respectively), it was more prevalent among those aged 30 to 
50 years (18.0% and 19.8%; Figure S4). Similar results were 
obtained when ambulatory hypertension was defined accord-
ing to 24-hour instead of daytime BP levels (Figure S5) or 
when awake BP was used instead of daytime ABP based on 
short fixed clock–time periods (Figure S6).
The overall prevalence of white coat hypertension was 
slightly higher in men than in women (8.0% versus 6.1%; 
P=0.0003), but showed a similar relationship with age in both 
sexes (Figure 3). Masked hypertension was more prevalent in 
men than in women (21.1% versus 11.4%; P<0.0001). In addi-
tion, the distribution across age categories markedly differed 
between men and women (Figure 3). Although in women, the 
prevalence of masked hypertension gradually increased from 
9.0% in the youngest age category to 14.7% among those aged 
60 to 70 years, there was an inverse U-shaped association among 
men, with the highest prevalence among men aged between 30 
and 50 years (27.3% and 27.8%, respectively). The prevalence of 
sustained hypertension was higher in men than in women across 
all age groups (22.1% versus 11.3%; P<0.0001), with a similar 
distribution across age categories in both sexes (Figure 3).
Discussion
In this large collaborative study of 13 population-based 
cohorts, we found that the difference between daytime ABP 
and CBP markedly differs according to age. Although CBP 
was significantly higher than daytime ABP among those 
aged ≥60 years, as has been described in many earlier stud-
ies, this association was inverse among individuals <50 years. 
Our results were robust to sensitivity analyses where differ-
ent definitions of ambulatory hypertension were used. The 
inverse relationship in younger individuals has received little 
attention previously,11–13 and most available studies mainly 
focused on the direct relationship between age and the white 
coat response.14,15 As in our work, these studies found that the 
white coat response increases with increasing age and that 
it was stronger among individuals with office hypertension. 
Some earlier studies found a higher prevalence of white coat 
hypertension among women.16 The differential findings in our 
study may be explained by the high number of younger indi-
viduals assessed (Figure 3).
CBPM is usually performed in a relatively standardized 
setting in the physician’s office, whereas daytime ABPM is 
obtained in the unstandardized individual real-life environ-
ment. As physical activity declines with increasing age,17 less 
exercise and a more sedentary behavior during ABPM may be 
one reason why daytime ABP is relatively higher than CBP 
in younger compared with older individuals. Furthermore, 
the observed age-dependent differences may also be partly 
explained by the fact that many individuals aged <60 years are 
part of the active workforce and many of the individuals aged 
≥60 years are retired. This hypothesis is in agreement with 
our finding that the prevalence of masked hypertension was 
much higher among men <50 years, as they more often have 
a physically demanding profession when compared with their 
female counterparts.
However, if these hypotheses are true, then the prognos-
tic relevance of masked hypertension in younger individu-
als is unclear, given that an increased physical activity has a 
Figure 3. Prevalence of white coat, masked, and sustained hypertension according to age and sex categories. P values given are 
based on a χ2 test comparing the age-specific prevalences between men and women. White coat hypertension was defined as elevated 
conventional blood pressure (BP) and normal ambulatory BP, masked hypertension was defined as normal conventional BP and elevated 
ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated ambulatory BP. Numbers indicate 
prevalences.
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favorable effect on various health outcomes.18 Several studies 
mostly among elderly individuals have shown that the out-
come among individuals with masked hypertension is similar 
to those with sustained hypertension,19,20 which is in agree-
ment with the finding that ABP is a better predictor of cardio-
vascular events than CBP and that the prognostic information 
is partly independent of CBP.3,4 Whether these strong associa-
tions between masked hypertension and cardiovascular events 
are transferable to younger, mainly male individuals, needs to 
be defined in prospective studies.
Taken together, we think that these findings may have impor-
tant implications for the diagnosis of hypertension. Our study 
suggests that age-specific cut-offs for daytime ABP may be 
considered. Prospective studies are needed to define these cut-
offs. If these studies show that the prognostic effect of masked 
hypertension is independent of age, then ABPM should be 
used more often in middle-aged men. The use of ABPM in 
individuals with nonhypertensive CBP is supported by recent 
findings showing that ABP also improves risk stratification 
in normotensive and prehypertensive individuals.21 Our data 
also show that, among individuals with office hypertension, a 
white coat effect is present in all age groups, although much 
higher among older individuals, such that algorithms looking 
for white coat hypertension proposed by current guidelines 
seem to be applicable independent of age.7
Strengths of the current analysis include the large sample 
size, the large number of young adults available for the study, 
and the population-based design of all cohorts included. 
Potential limitations that need to be taken into account in 
the interpretation of this study include the following. First, 
assessments of anthropometric characteristics differed across 
cohorts. Second, CBPM and ABPM were not standardized 
with regard to device used and intervals set between mea-
surements. However, all daytime and nighttime periods in all 
IDACO cohorts were calculated in a homogenous fashion, as 
described previously.22 Third, the number of nonwhite indi-
viduals was small and heterogeneous, such that we cannot 
exclude a differential relationship between daytime ABP and 
CBP in some other populations. Finally, this was a cross-sec-
tional study, and the prognostic significance of our findings 
needs to be evaluated in future studies.
Perspectives
In this large collaborative study of 9550 individuals across a wide 
age range, we describe important age-dependent differences in 
the relationship between CBP and daytime ABP. In individu-
als aged <50 years, daytime ABP was significantly higher than 
CBP, whereas the inverse was found in those aged ≥60 years. 
These findings may have important implications for the diag-
nosis of hypertension and its subtypes, although the prognostic 
significance of our results needs to be defined in future studies.
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What Is New?
•	This is the first large study to compare individual conventional and day-
time ambulatory blood pressure (BP) values across a wide age range.
What Is Relevant?
•	Among individuals aged <50 years, mean daytime ambulatory BP was 
significantly higher than conventional BP.
•	Among individuals aged ≥60 years, conventional BP was significantly 
higher than mean daytime ambulatory BP.
•	The prevalence of white coat and masked hypertension strongly var-
ied by age. White coat hypertension exponentially increased with age, 
with little variation between men and women. Masked hypertension was 
more prevalent among men (21.1% versus 11.4%; P<0.0001), with the 
highest prevalence among men aged 30 to 50 years.
Summary
We found important age-dependent differences in the relationship 
between conventional daytime ambulatory BP. These findings may 
have important implications for the diagnosis of hypertension and 
its subtypes.
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Expanded methods 
Blood pressure measurement 
Conventional blood pressure was measured by trained observers with a mercury 
sphygmomanometer, 1-7 with validated auscultatory 8 (USM-700F, UEDA Electronic 
Works, Tokyo, Japan) or oscillometric 9, 10 (OMRON HEM-705CP, Omron 
Corporation, Tokyo, Japan; Microlife BP3AG1, Switzerland) devices, using the 
appropriate cuff size, with participants in the sitting position. For the present study, 
only sitting blood pressure values were used. Conventional blood pressure was the 
average of two consecutive readings obtained either at the person’s home 1-4, 9 or at 
an examination center. 5-8, 10  
We programmed portable monitors to obtain ambulatory blood pressure readings at 
30 minute intervals throughout the whole day, 8 or at intervals ranging from 15 1, 2, 5, 10 
to 30 8 minutes during daytime and from 20 6 to 45 3 minutes at night. Detailed 
information on the time intervals between readings, numbers of programmed and 
recorded readings in each cohort are shown in Table S1. The devices implemented 
an auscultatory algorithm (Accutracker II) in Uppsala, 6 an oscillometric technique 
(SpaceLabs 90202 and 90207, Nippon Colin, and ABPM 630), 1-5, 7, 8 or a 
combination of the two (Schiller BR-102 plus). 10 According to predefined criteria,11 
recordings with <10 daytime readings or <5 nighttime readings were excluded from 
the analyses.  
In seven cohorts (Ohasama, Uppsala, JingNing, Pilsen, Dublin, Padua, 
Liechtenstein), ambulatory blood pressure and conventional blood pressure 
monitoring were performed on the same day in virtually all subjects. In 
Noorderkempen ambulatory blood pressure and conventional blood pressure 
monitoring were performed within 2 weeks in all but 6 subjects. In Maracaibo 
ambulatory blood pressure and conventional blood pressure monitoring were 
performed within 2 weeks in >92% of the subjects In Krakow ambulatory blood 
pressure and conventional blood pressure monitoring were performed within 2 days 
in all but 2 subjects. In Novosibirsk, Montevideo and Copenhagen ambulatory blood 
pressure and conventional blood pressure monitoring were performed within 2 weeks 
in 71%, 94% and 80% of the subjects respectively.  
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Table S1: Number of 24 hour ambulatory blood pressure readings in IDACO cohorts and GAPP 
IDACO Cohorts N of 
Subjects 
Interval between 
Readings (minutes)
N of 
programmed 
Readings 
N of Recorded Readings 
N=9550 Daytime Nighttime Median P5 P25 P75 P95 
Copenhagen County, Denmark 1823 15 30 80 80 67 78 81 83 
Ohasama, Iwate prefecture, Japan 851 30 30 48 46 36 42 48 50 
Noorderkempen, Belgium 1175 20 40 55 53 38 41 56 58 
Montevideo, Uruguay 1188 20 40 60 38 30 35 40 43 
JingNing, Zhejiang, China 299 20 45 65 56 52 55 56 57 
Octyabrsky District, Novosibirsk, 
Russia 204 15 30 76 72 57 65 76 78 
Pilsen, Czech Republic 133 15 30 76 76 54 71 80 82 
Dublin, Ireland 930 30 30 48 46 38 44 48 49
Padua, Italy 266 15 30 76 77 65 74 78 84 
Niepolomice, Kraków, Poland 244 15 30 76 75 63 72 77 79 
Maracaibo, Venezuela 393 15 30 81 67 50 61 71 78 
Schaan, Liechtenstein 2044 15 30 76 75 63 72 76 77 
N = number; IDACO= International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes; GAPP= genetic 
and phenotypic determinants of blood pressure and other cardiovascular risk factors.  
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Table S2 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
 
N=7185. Daytime ambulatory blood pressure was defined individually according to diary based information. Participants with missing 
information on awake BP were excluded. Data are means ± standard deviation.  
SBP = systolic blood pressure, DBP = diastolic blood pressure 
 
  
Age 
(years) 
N Conventional SBP 
(mmHg) 
Daytime SBP 
(mmHg) 
SBP difference 
(mmHg) 
Conventional DBP 
(mmHg) 
Daytime DBP 
(mmHg) 
DBP difference 
(mmHg) 
18-30 1035 117.2 ± 12.7 123.5 ± 11.8 -6.3 ± 9.8 74.7 ± 8.9 76.4 ± 8.1 -1.7 ± 7.8 
30-40 1612 119.0 ± 13.1  124.6 ± 11.9 -5.6 ± 10.1 77.6 ± 9.3 80.2 ± 8.6 -2.6 ± 7.5 
40-50 1710 121.3 ± 15.2 125.9 ± 12.4 -4.6 ± 11.9 78.8 ± 10.4 80.0 ± 9.4 -1.2 ± 8.5 
50-60 1301 126.9 ± 17.4 127.9 ± 13.2 -1.0 ± 14.0 79.8 ± 11.4 78.8 ± 9.1 1.0 ± 9.0 
60-70 1002 134.0 ± 19.6 131.3 ± 14.2 2.7 ± 15.8 80.0 ± 11.7 78.7 ± 8.9 1.3 ± 9.3 
≥70 525 140.1 ± 18.2 134.4 ± 14.2 5.7 ± 15.5 79.7 ± 10.7 77.0 ± 8.8 2.7 ± 9.6 
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Table S3 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
Age N Conventional SBP Daytime SBP SBP difference Conventional DBP Daytime DBP DBP difference 
18-30 608 117.3 ± 12.7 123.6 ± 12.1 -6.3 ± 9.5 75.7 ± 8.5  76.4 ± 10.0 -0.7 ± 7.3 
30-40 1294 118.9 ± 12.7  124.8 ± 11.9 -5.9 ± 9.4 77.8 ± 8.9 78.8 ± 10.9 -1.0 ± 7.0 
40-50 831 121.1 ± 15.5 125.8 ± 13.2 -4.7 ± 10.4 79.2 ± 10.2 80.9 ± 10.6 -1.7 ± 7.9 
50-60 288 136.9 ± 25.2 127.3 ± 15.3 9.6 ± 18.6 83.2 ± 12.6 81.4 ± 10.4 1.8 ± 10.2 
60-70 353 148.9 ± 28.5 128.9 ± 15.4 20.0 ± 22.3 82.7 ± 12.5 78.7 ± 9.6 4.0 ± 10.7 
≥70 251 166.7 ± 34.1 135.2 ± 16.4 31.5 ± 29.4 85.7 ± 15.3 77.6 ± 11.1 8.1 ± 14.6 
 
N=3625. Only cohorts with available data on oscillometric recordings for both conventional and ambulatory blood pressure monitoring 
were considered (Montevideo, Uruguay; Maracaibo, Venezuela; Schaan, Liechtenstein) 
SBP = systolic blood pressure, DBP = diastolic blood pressure 
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Table S4 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
 
N=7229. Only cohorts with where conventional BP was measured in the clinic were considered (Dublin, Ireland; Montevideo, Uruguay; 
Maracaibo, Venezuela; Ohasama, Japan; Copenhagen, Denmark; Schaan, Liechtenstein)  
SBP = systolic blood pressure, DBP = diastolic blood pressure 
 
 
  
Age N Conventional SBP Daytime SBP SBP difference Conventional DBP Daytime DBP DBP difference 
18-30 927 116.5 ± 12.8 123.2 ± 11.4 -6.7 ± 9.8 74.2 ± 8.9 76.9 ± 7.9 -2.7 ± 7.6 
30-40 1593 118.5 ± 12.7  124.2 ± 11.6 -5.7 ± 9.6 77.2 ± 8.9 80.0 ± 8.2 -2.8 ± 7.1 
40-50 1632 120.8 ± 15.2 127.0 ± 12.9 -6.2 ± 12.0 78.5 ± 10.5 80.6 ± 9.5 -2.1 ± 8.1 
50-60 1217 128.5 ± 20.0 129.9 ± 14.4 -1.4 ± 16.7 80.2 ± 12.2 79.7 ± 10.0 0.5 ± 9.8 
60-70 1221 137.7 ± 22.9 132.8 ± 14.6 4.9 ± 20.6 81.3. ± 12.2 79.1 ± 9.2 2.2 ± 10.1 
≥70 639 149.9 ± 28.6 136.5 ± 15.3 13.4 ± 26.1 82.4 ± 13.0 77.6 ± 9.9 4.8 ± 11.9 
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Figure S1 Differences between conventional and ambulatory daytime blood pressures according to age categories in 2254 
individuals with office hypertension 
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Figure S2 Differences between conventional and ambulatory daytime blood pressures according to age categories among men 
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Figure S3 Differences between conventional and ambulatory daytime blood pressures according to age categories among women 
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Figure S4 Prevalence of white coat, masked and sustained hypertension according to age categories 
n= 9550. Daytime ambulatory blood pressure was defined according to short fixed clock-time periods.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP. Numbers indicate prevalences.  
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Figure S5 Prevalence of white coat, masked and sustained hypertension according to age categories 
n= 9550. Ambulatory hypertension was defined as 24h blood pressure ≥130 for systolic or ≥80mmHg for diastolic blood pressure.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP.  
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Figure S6 Prevalence of white coat, masked and sustained hypertension according to age categories  
N= 7185. Daytime ambulatory blood pressure was defined individually according to diary based information. Participants with missing 
information on awake BP were excluded.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP 
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Expanded methods 
Blood pressure measurement 
Conventional blood pressure was measured by trained observers with a mercury 
sphygmomanometer, 1-7 with validated auscultatory 8 (USM-700F, UEDA Electronic 
Works, Tokyo, Japan) or oscillometric 9, 10 (OMRON HEM-705CP, Omron 
Corporation, Tokyo, Japan; Microlife BP3AG1, Switzerland) devices, using the 
appropriate cuff size, with participants in the sitting position. For the present study, 
only sitting blood pressure values were used. Conventional blood pressure was the 
average of two consecutive readings obtained either at the person’s home 1-4, 9 or at 
an examination center. 5-8, 10  
We programmed portable monitors to obtain ambulatory blood pressure readings at 
30 minute intervals throughout the whole day, 8 or at intervals ranging from 15 1, 2, 5, 10 
to 30 8 minutes during daytime and from 20 6 to 45 3 minutes at night. Detailed 
information on the time intervals between readings, numbers of programmed and 
recorded readings in each cohort are shown in Table S1. The devices implemented 
an auscultatory algorithm (Accutracker II) in Uppsala, 6 an oscillometric technique 
(SpaceLabs 90202 and 90207, Nippon Colin, and ABPM 630), 1-5, 7, 8 or a 
combination of the two (Schiller BR-102 plus). 10 According to predefined criteria,11 
recordings with <10 daytime readings or <5 nighttime readings were excluded from 
the analyses.  
In seven cohorts (Ohasama, Uppsala, JingNing, Pilsen, Dublin, Padua, 
Liechtenstein), ambulatory blood pressure and conventional blood pressure 
monitoring were performed on the same day in virtually all subjects. In 
Noorderkempen ambulatory blood pressure and conventional blood pressure 
monitoring were performed within 2 weeks in all but 6 subjects. In Maracaibo 
ambulatory blood pressure and conventional blood pressure monitoring were 
performed within 2 weeks in >92% of the subjects In Krakow ambulatory blood 
pressure and conventional blood pressure monitoring were performed within 2 days 
in all but 2 subjects. In Novosibirsk, Montevideo and Copenhagen ambulatory blood 
pressure and conventional blood pressure monitoring were performed within 2 weeks 
in 71%, 94% and 80% of the subjects respectively.  
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Table S1: Number of 24 hour ambulatory blood pressure readings in IDACO cohorts and GAPP 
IDACO Cohorts N of 
Subjects 
Interval between 
Readings (minutes)
N of 
programmed 
Readings 
N of Recorded Readings 
N=9550 Daytime Nighttime Median P5 P25 P75 P95 
Copenhagen County, Denmark 1823 15 30 80 80 67 78 81 83 
Ohasama, Iwate prefecture, Japan 851 30 30 48 46 36 42 48 50 
Noorderkempen, Belgium 1175 20 40 55 53 38 41 56 58 
Montevideo, Uruguay 1188 20 40 60 38 30 35 40 43 
JingNing, Zhejiang, China 299 20 45 65 56 52 55 56 57 
Octyabrsky District, Novosibirsk, 
Russia 204 15 30 76 72 57 65 76 78 
Pilsen, Czech Republic 133 15 30 76 76 54 71 80 82 
Dublin, Ireland 930 30 30 48 46 38 44 48 49
Padua, Italy 266 15 30 76 77 65 74 78 84 
Niepolomice, Kraków, Poland 244 15 30 76 75 63 72 77 79 
Maracaibo, Venezuela 393 15 30 81 67 50 61 71 78 
Schaan, Liechtenstein 2044 15 30 76 75 63 72 76 77 
N = number; IDACO= International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes; GAPP= genetic 
and phenotypic determinants of blood pressure and other cardiovascular risk factors.  
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Table S2 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
 
N=7185. Daytime ambulatory blood pressure was defined individually according to diary based information. Participants with missing 
information on awake BP were excluded. Data are means ± standard deviation.  
SBP = systolic blood pressure, DBP = diastolic blood pressure 
 
  
Age 
(years) 
N Conventional SBP 
(mmHg) 
Daytime SBP 
(mmHg) 
SBP difference 
(mmHg) 
Conventional DBP 
(mmHg) 
Daytime DBP 
(mmHg) 
DBP difference 
(mmHg) 
18-30 1035 117.2 ± 12.7 123.5 ± 11.8 -6.3 ± 9.8 74.7 ± 8.9 76.4 ± 8.1 -1.7 ± 7.8 
30-40 1612 119.0 ± 13.1  124.6 ± 11.9 -5.6 ± 10.1 77.6 ± 9.3 80.2 ± 8.6 -2.6 ± 7.5 
40-50 1710 121.3 ± 15.2 125.9 ± 12.4 -4.6 ± 11.9 78.8 ± 10.4 80.0 ± 9.4 -1.2 ± 8.5 
50-60 1301 126.9 ± 17.4 127.9 ± 13.2 -1.0 ± 14.0 79.8 ± 11.4 78.8 ± 9.1 1.0 ± 9.0 
60-70 1002 134.0 ± 19.6 131.3 ± 14.2 2.7 ± 15.8 80.0 ± 11.7 78.7 ± 8.9 1.3 ± 9.3 
≥70 525 140.1 ± 18.2 134.4 ± 14.2 5.7 ± 15.5 79.7 ± 10.7 77.0 ± 8.8 2.7 ± 9.6 
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Table S3 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
Age N Conventional SBP Daytime SBP SBP difference Conventional DBP Daytime DBP DBP difference 
18-30 608 117.3 ± 12.7 123.6 ± 12.1 -6.3 ± 9.5 75.7 ± 8.5  76.4 ± 10.0 -0.7 ± 7.3 
30-40 1294 118.9 ± 12.7  124.8 ± 11.9 -5.9 ± 9.4 77.8 ± 8.9 78.8 ± 10.9 -1.0 ± 7.0 
40-50 831 121.1 ± 15.5 125.8 ± 13.2 -4.7 ± 10.4 79.2 ± 10.2 80.9 ± 10.6 -1.7 ± 7.9 
50-60 288 136.9 ± 25.2 127.3 ± 15.3 9.6 ± 18.6 83.2 ± 12.6 81.4 ± 10.4 1.8 ± 10.2 
60-70 353 148.9 ± 28.5 128.9 ± 15.4 20.0 ± 22.3 82.7 ± 12.5 78.7 ± 9.6 4.0 ± 10.7 
≥70 251 166.7 ± 34.1 135.2 ± 16.4 31.5 ± 29.4 85.7 ± 15.3 77.6 ± 11.1 8.1 ± 14.6 
 
N=3625. Only cohorts with available data on oscillometric recordings for both conventional and ambulatory blood pressure monitoring 
were considered (Montevideo, Uruguay; Maracaibo, Venezuela; Schaan, Liechtenstein) 
SBP = systolic blood pressure, DBP = diastolic blood pressure 
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Table S4 Differences between conventional and ambulatory daytime blood pressures according age categories 
 
 
N=7229. Only cohorts with where conventional BP was measured in the clinic were considered (Dublin, Ireland; Montevideo, Uruguay; 
Maracaibo, Venezuela; Ohasama, Japan; Copenhagen, Denmark; Schaan, Liechtenstein)  
SBP = systolic blood pressure, DBP = diastolic blood pressure 
 
 
  
Age N Conventional SBP Daytime SBP SBP difference Conventional DBP Daytime DBP DBP difference 
18-30 927 116.5 ± 12.8 123.2 ± 11.4 -6.7 ± 9.8 74.2 ± 8.9 76.9 ± 7.9 -2.7 ± 7.6 
30-40 1593 118.5 ± 12.7  124.2 ± 11.6 -5.7 ± 9.6 77.2 ± 8.9 80.0 ± 8.2 -2.8 ± 7.1 
40-50 1632 120.8 ± 15.2 127.0 ± 12.9 -6.2 ± 12.0 78.5 ± 10.5 80.6 ± 9.5 -2.1 ± 8.1 
50-60 1217 128.5 ± 20.0 129.9 ± 14.4 -1.4 ± 16.7 80.2 ± 12.2 79.7 ± 10.0 0.5 ± 9.8 
60-70 1221 137.7 ± 22.9 132.8 ± 14.6 4.9 ± 20.6 81.3. ± 12.2 79.1 ± 9.2 2.2 ± 10.1 
≥70 639 149.9 ± 28.6 136.5 ± 15.3 13.4 ± 26.1 82.4 ± 13.0 77.6 ± 9.9 4.8 ± 11.9 
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Figure S1 Differences between conventional and ambulatory daytime blood pressures according to age categories in 2254 
individuals with office hypertension 
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Figure S2 Differences between conventional and ambulatory daytime blood pressures according to age categories among men 
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Figure S3 Differences between conventional and ambulatory daytime blood pressures according to age categories among women 
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Figure S4 Prevalence of white coat, masked and sustained hypertension according to age categories 
n= 9550. Daytime ambulatory blood pressure was defined according to short fixed clock-time periods.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP. Numbers indicate prevalences.  
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Figure S5 Prevalence of white coat, masked and sustained hypertension according to age categories 
n= 9550. Ambulatory hypertension was defined as 24h blood pressure ≥130 for systolic or ≥80mmHg for diastolic blood pressure.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP.  
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Figure S6 Prevalence of white coat, masked and sustained hypertension according to age categories  
N= 7185. Daytime ambulatory blood pressure was defined individually according to diary based information. Participants with missing 
information on awake BP were excluded.  
White coat hypertension was defined as elevated conventional BP and normal ambulatory BP, masked hypertension was defined as 
normal conventional BP and elevated ambulatory BP, sustained hypertension was defined as elevated conventional BP and elevated 
ambulatory BP 
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